Skip to main content
Log in

Sales revenue from cancer drugs have increased by 96% over the past decade

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The companies included Abbvie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche and Sanofi.

Reference

  • Meyers DE, et al. Temporal trends in oncology drug revenue among the world's major pharmaceutical companies: A 2010-2019 cohort study. 57th Annual Meeting of the American Society of Clinical Oncology : abstr. 6505, 4 Jun 2021. Available from: URL: https://meetinglibrary.asco.org/record/196652/abstract

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sales revenue from cancer drugs have increased by 96% over the past decade. PharmacoEcon Outcomes News 883, 28 (2021). https://doi.org/10.1007/s40274-021-7899-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7899-1

Navigation